IOP increase of ≥ 10 mmHg within 2 hours · people with glaucoma receiving LTP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dropout · patients with the treatment of cocaine dependence
Any antipsychotic probably leads to lower dropouts Number of participants who dropped out from the study compared with placebo (moderate certainty).
1 finding from 1 review
Participants with at least some Side Effects · patients with the treatment of cocaine dependence
Any antipsychotic showed no clear difference in side effects Number of participants with at least i side effect compared with placebo (low certainty).
1 finding from 1 review
Number of participants using cocaine during the treatment (as days/week by urine tests or self report) Number of participants that reported the use of cocaine during the treatment · patients with the treatment of cocaine dependence
Any antipsychotic showed no clear difference in number of participants using cocaine during the treatment (as… compared with placebo (low certainty).
1 finding from 1 review
Continuous abstinence (number of participants who maintained negative drug screens for 2 ‐ 3 weeks) Number of participants that maintained negative cocaine screens for at least 2 ‐ 3 weeks · patients with the treatment of cocaine dependence
Any antipsychotic showed no clear difference in continuous abstinence (number of participants who maintained… compared with placebo (low certainty).
1 finding from 1 review
Craving · patients with the treatment of cocaine dependence
1 finding from 1 review
Intervention not reported
Health‐related quality of life [measured by the validated questionnaire SF‐36]
1 finding from 1 review
Intervention not reported
Development and worsening of Graves' ophthalmopathy [examination by ophthalmologists]
The intervention may leads to higher development and worsening of Graves' ophthalmopathy [examination by… (low certainty).
1 finding from 1 review
Intervention not reported
Individuals in euthyroid state [measured by serum thyroid hormone levels within the normal range]
1 finding from 1 review
Intervention not reported
Recurrence of hyperthyroidism (relapse) [measured by serum thyroid hormone levels above the normal range after withdrawal of methimazole or end of radioiodine treatment]
It is very uncertain whether the intervention changes recurrence of hyperthyroidism (relapse) [measured by serum thyroid… (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events other than development or worsening of Graves' disease (a) Hypothyroidism [measured by TSH and/or thyroid hormones] (b) Drug reactions
1 finding from 1 review
Intervention not reported
All‐cause mortality
1 finding from 1 review
Intervention not reported
Socioeconomic effects [costs per patient, based on the official hospital reimbursement system in Sweden]
1 finding from 1 review
Intervention not reported
Serious MEs (ICU)
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
MEs
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Harmful ADEs
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Potentially harmful ADEs
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
BCMA vs no BCMA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Targeted preventable ADEs
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Potential ADEs
1 finding from 1 review
no estimate extracted
Studies not reported
Low